Discover the future through innovation in our Preclinical Laboratories: where science becomes progress.
Welcome to our Preclinical and Laboratory section, where innovation drives our commitment to taking scientific research to new heights. In our state-of-the-art laboratory, we combine cutting-edge technology with the expertise of our highly qualified team to conduct high-level preclinical studies.
Our focus is on exploring new horizons and discovering revolutionary solutions to the most pressing medical challenges. We work closely with academic partners, research institutions and biotech companies to accelerate the development of innovative therapies.
Our expertise ranges from safety and efficacy assessment of pharmacological compounds to biomarker discovery and toxicology analysis. We use rigorous and validated methods to ensure the accuracy and reliability of our results.
In our laboratory, innovation is the driving force that constantly drives us forward. We strive to be at the forefront of scientific and technological advances, adopting new tools and approaches to continuously improve our research capabilities.
We are proud to collaborate closely with some of the most prominent and renowned scientific centres. We take advantage of their expertise and state-of-the-art facilities to conduct high-level preclinical research.
We have a highly skilled team of scientists and researchers who possess in-depth knowledge in the field of preclinical research and laboratories. Our team is committed to scientific excellence and strives to keep abreast of the latest advances.
We collaborate with scientific centres that have facilities equipped with cutting-edge technology. This allows us to conduct preclinical research using the most advanced equipment and innovative techniques to obtain accurate and reliable results.
We are committed to conducting all our research in accordance with the highest ethical standards and respecting the confidentiality of our clients’ information. We maintain a relationship of trust with our partners and work closely together to protect the integrity of the data and results obtained.
If you are looking for a reliable and dedicated partner to conduct cutting-edge preclinical studies, you are in the right place. We pride ourselves on providing customised, collaborative solutions that enable our clients and partners to achieve their research and development goals.
Explore our website to learn more about our services, facilities and achievements. We are excited to collaborate with you and be part of your journey towards medical innovation.
INTRODUCTION Tecartus is a new advanced therapy approved to treat adults with mantle cell lymphoma (MCL)¹. This disease is a lymphatic system cancer. Specifically, it
INTRODUCTION Kymriah (Novartis) is an advanced therapy medicine that belongs to the gene therapyproduct category. It is approved for B-cell acute lymphoblastic leukemia (ALL) in
INTRODUCTION ¹. CARVYKTI™ (ciltacabtagene autoleucel – Johnson & Johnson) was approved by the U.S. Food and Drug Administration (FDA) in February 2022 for the treatment
